H

Health Initiatives Research, PLLC | Fayetteville, AR

Research site

(Unclaimed)

Location

2233 N. Green Acres Road, Fayetteville, Arkansas, United States of America

Site insights

Top conditions

Top treatments

AVP-786

Gantenerumab

LY3002813

Crenezumab

Donanemab

Aducanumab

Ranibizumab

AGN-241751

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 10 total trials

A Study of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME (BAROLO)

EYE-RES-103 is a randomized, double masked pivotal study to evaluate the efficacy and safety of 2 dose levels of EYE103 in comparison with the active...

Enrolling

Diabetic Macular Edema (DME)

Drug: EYE103

Drug: Ranibizumab

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.Additional part...

Active, not recruiting

Alzheimer Disease

Drug: Donanemab

Drug: Placebo